Elmwood Wealth Management Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,603 shares of the healthcare conglomerate’s stock after selling 120 shares during the quarter. Elmwood Wealth Management Inc.’s holdings in UnitedHealth Group were worth $2,834,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group during the third quarter valued at $27,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the third quarter worth about $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter worth about $37,000. Finally, Quarry LP lifted its stake in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on UNH shares. Stephens boosted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. TD Cowen upped their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Oppenheimer increased their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research note on Friday. Finally, Barclays raised their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $626.79.
UnitedHealth Group Price Performance
Shares of UNH traded up $21.57 during mid-day trading on Monday, hitting $542.26. 4,448,515 shares of the company were exchanged, compared to its average volume of 4,219,169. The stock has a market cap of $499.03 billion, a price-to-earnings ratio of 35.33, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a 50 day moving average of $555.25 and a 200-day moving average of $562.50.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What is a Low P/E Ratio and What Does it Tell Investors?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- The 3 Best Fintech Stocks to Buy Now
- Delta Can Fly to New Highs in 2025; Here’s Why
- Stock Sentiment Analysis: How it Works
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.